| |
Values
|
|---|
|
Subject number
|
327
|
|
Age
|
44.21 ± 11.22
|
|
Gender
|
|
Male
|
280 (85.63%)
|
|
Female
|
47 (14.37%)
|
|
Liver Histology
|
|
ISHAK Fibrosis Stages
|
|
0
|
2 (0.61%)
|
|
1
|
40 (12.23%)
|
|
2
|
51 (15.60%)
|
|
3
|
110 (33.64%)
|
|
4
|
33 (10.09%)
|
|
5
|
74 (22.63%)
|
|
6
|
17 (5.20%)
|
|
Piecemeal necrosis
|
|
0
|
101 (30.89%)
|
|
1
|
165 (50.46%)
|
|
2
|
47 (14.37%)
|
|
3
|
14 (4.28%)
|
|
Confluent necrosis
|
|
0
|
307 (93.88%)
|
|
1
|
6 (1.83%)
|
|
2
|
2 (0.61%)
|
|
3
|
1 (0.31%)
|
|
4
|
10 (3.06%)
|
|
5
|
1 (0.31%)
|
|
Focal (spotty) lytic necrosis, apoptosis and focal inflammation
|
|
0
|
2 (0.61%)
|
|
1
|
93 (28.44%)
|
|
2
|
161 (49.24%)
|
|
3
|
67 (20.49%)
|
|
4
|
4 (1.22%)
|
|
Portal inflammation
|
|
0
|
6 (1.83%)
|
|
1
|
77 (23.55%)
|
|
2
|
103 (31.50%)
|
|
3
|
123 (37.61%)
|
|
4
|
17 (5.20%)
|
|
5
|
1 (0.31%)
|
|
Viral serology
|
|
HBV DNA (log10 IU/ml)
|
6.35 ± 1.71
|
|
HBeAg positive
|
146 (44.65%)
|
|
HBsAg (log10 IU/ml)
|
3.33 ± 0.98
|
|
Hematology
|
|
ALT (IU/L)
|
177.31 ± 173.34
|
|
AST (IU/L)
|
106.96 ± 122.57
|
|
Bilirubin (mg/dL)
|
0.98 ± 0.42
|
|
Albumin (g/dL)
|
4.55 ± 0.35
|
|
Gamma-glutamyltransferase (IU/L)
|
59.53 ± 46.75
|
|
Platelet (1000/mm3)
|
189.78 ± 50.31
|
|
Hemoglobin (g/dL)
|
15.20 ± 1.36
|
